- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT00572624
Effect of Weight Loss on Myocardial Metabolism and Cardiac Relaxation in Obese Adults
maanantai 8. toukokuuta 2017 päivittänyt: Washington University School of Medicine
Effect of Weight Loss on Myocardial Oxygen Consumption and Left Ventricular Relaxation in Obese Adults
Obesity adversely affects myocardial (muscular heart tissue) metabolism, efficiency, and diastolic function.
The objective of this study was to determine if weight loss could improve obesity-related myocardial metabolism and efficiency and if these improvements were directly related to improved diastolic function.
Tutkimuksen yleiskatsaus
Tila
Valmis
Ehdot
Interventio / Hoito
Yksityiskohtainen kuvaus
This was a prospective, interventional study in obese adults ages 21 to 50 years of age to determine whether weight loss could improve obesity-related myocardial metabolism and efficiency.
Two different mechanisms of weight loss were studied: diet and exercise and gastric bypass surgery.
Positron emission tomography (PET) was used to quantitate myocardial oxygen consumption (MVO2) and myocardial fatty acid (FA) metabolism.
Echocardiography with tissue Doppler imaging was used to quantify cardiac structure, systolic and diastolic function (left ventricular (LV) relaxation (E') and septal ratio (E/E')).
Opintotyyppi
Interventio
Ilmoittautuminen (Todellinen)
51
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.
Opiskelupaikat
-
-
Missouri
-
Saint Louis, Missouri, Yhdysvallat, 63110
- Washington University Medical School
-
-
Osallistumiskriteerit
Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.
Kelpoisuusvaatimukset
Opintokelpoiset iät
21 vuotta - 50 vuotta (Aikuinen)
Hyväksyy terveitä vapaaehtoisia
Joo
Sukupuolet, jotka voivat opiskella
Kaikki
Kuvaus
Inclusion Criteria:
- Body mass index (BMI) > 30 kg/m^2
- Sedentary lifestyle
Exclusion Criteria:
- Body weight >159 kg
- Insulin-requiring diabetes
- Heart failure
- History of coronary artery disease
- Chest pain
- Untreated sleep apnea
- Being an active smoker
- Pregnant, lactating, or postmenopausal
Opintosuunnitelma
Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Perustiede
- Jako: Ei satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Ei mitään (avoin tarra)
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
---|---|
Kokeellinen: Diet
Participants who received counseling and instruction about weight loss through diet and exercise
|
Participants attended 20 group behavioral modification sessions led by a behaviorist, a registered dietician, and a physical therapist.
The meal plans ranged from 1200 to 1500 kilocalories per day, depending on subject sex and BMI, and were designed to achieve ≤1% body weight loss/week.
Participants completed daily food records, and were taught a variety of weight management skills.
The exercise component included strength, flexibility, balance, and endurance instruction, gradually increasing to 30 minutes of exercise 5 days/week.
|
Kokeellinen: Gastric bypass surgery
Participants who received gastric bypass surgery
|
The same surgeon performed all bypass procedures using standard techniques.
A small (~20 ml) proximal gastric pouch was created by stapling the stomach, and a 75-cm Roux-en-Y limb was constructed by transecting the jejunum distal to the ligament of Treitz, and creating a jejunojejunostomy 75 cm distal to the transection.
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
---|---|---|
Total Myocardial Oxygen Consumption (MVO2)
Aikaikkuna: Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
The evening before an imaging study, all participants were given a meal containing 12 kcal/kg adjusted body weight (=ideal body weight + ((actual body weight-ideal body weight) x 0.25)).
Participants fasted until their imaging studies were completed.
Myocardial oxygen consumption (MVO2) was measured using positron emission tomography (PET) following injection of 1-^11C-acetate.
Total MVO2 was calculated by multiplying the MVO2 measure by left ventricular weight.
|
Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
Total Myocardial Fatty Acid (FA) Utilization
Aikaikkuna: Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
The evening before an imaging study, all participants were given a meal containing 12 kcal/kg adjusted body weight (=ideal body weight + ((actual body weight-ideal body weight) x 0.25)).
Participants fasted until their imaging studies were completed.
Myocardial blood flow was measured using positron emission tomography (PET) following injection of ^30O-water.
Myocardial fatty acid (FA) utilization was measured using PET after injection of 1-^11C-palmitate.
The calculations that describe the relationship between the different measures of myocardial FA metabolism are: FA utilization/gram = blood flow/gram × FA uptake/gram × [average plasma free FA at the time of the 1-11C-palmitate injection]; FA utilization/gram = FA oxidation/gram + esterification/gram.
Total fatty acid utilization was calculated by multiplying the fatty acid utilization rate by left ventricular weight.
|
Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
Total Myocardial Fatty Acid (FA) Oxidation
Aikaikkuna: Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
The evening before an imaging study, all participants were given a meal containing 12 kcal/kg adjusted body weight (=ideal body weight + ((actual body weight-ideal body weight) x 0.25)).
Participants fasted until their imaging studies were completed.
Myocardial fatty acid utilization was measured using positron emission tomography (PET) after injecting 1-^11C-palmitate.
Total fatty acid oxidation was calculated by multiplying the fatty acid oxidation rate by left ventricular weight.
|
Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
---|---|---|
Left Ventricular (LV) Relaxation (E')
Aikaikkuna: Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
Immediately following MVO2 measurement, complete two-dimensional, M-mode, and Doppler echocardiographic studies were performed using second harmonic imaging.
Left ventricular relaxation (E') was measured at the lateral annulus.
All reported measurements represent the average of three consecutive cardiac cycles.
A single investigator blinded to all clinical parameters evaluated all echocardiograms.
|
Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
Septal Ratio (E/E')
Aikaikkuna: Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
Immediately following MVO2 measurement, complete two-dimensional, M-mode, and Doppler echocardiographic studies were performed using second harmonic imaging.
The early diastolic (E) velocity was measured, left ventricular relaxation (E') was measured at the lateral mitral annulus, and the E/E'(septal) ratio was calculated.
All reported measurements represent the average of three consecutive cardiac cycles.
A single investigator blinded to all clinical parameters evaluated all echocardiograms.
The normal septal ratio from the lateral mitral annulus is <5, a ratio from 5 to 10 is indeterminate, and a ratio of >10 indicates elevated left atrial pressure.
|
Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
Left Ventricular (LV) Mass
Aikaikkuna: Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
Immediately following MVO2 measurement, complete two-dimensional, M-mode, and Doppler echocardiographic study were performed using second harmonic imaging.
Left ventricular (LV) mass was measured using the area-length method.
All reported measurements represent the average of three consecutive cardiac cycles.
A single investigator blinded to all clinical parameters evaluated all echocardiograms.
|
Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
Mean Heart Rate
Aikaikkuna: Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
Heart rate was measured at scheduled physical examinations.
|
Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
Mean Arterial Pressure
Aikaikkuna: Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
Mean arterial pressure was measured at scheduled physical examinations.
|
Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
Mean Body Mass Index
Aikaikkuna: Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
Participant weight and height was measured at scheduled physical examinations.
Body mass index was calculated as participant body weight in kilograms divided by their height in meters squared.
|
Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
Mean Total Serum Cholesterol and Triglycerides
Aikaikkuna: Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
Blood testing was conducted at scheduled times during the study.
Serum cholesterol and triglycerides were measured by the enzymatic method (Roche Diagnostics).
|
Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
Mean Homeostasis Model Assessment of Insulin Resistance
Aikaikkuna: Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
The homeostasis model assessment of insulin resistance (HOMA) was used to calculate insulin resistance using the first AM, fasting glucose and insulin levels.
Plasma insulin levels were measured by radioimmunoassay, and glucose levels were measured by automated hexokinase assay.
A HOMA score of <3 represents normal insulin resistance, a score between 3 and 5 moderate insulin resistance, and a score of 5 or higher represents severe insulin resistance.
|
Measured at baseline, 16 months after gastric bypass surgery-induced weight loss, and 8 months after diet-induced weight loss
|
Yhteistyökumppanit ja tutkijat
Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.
Yhteistyökumppanit
Tutkijat
- Päätutkija: Robert Gropler, MD, Washington University Medical School
Julkaisuja ja hyödyllisiä linkkejä
Tutkimusta koskevien tietojen syöttämisestä vastaava henkilö toimittaa nämä julkaisut vapaaehtoisesti. Nämä voivat koskea mitä tahansa tutkimukseen liittyvää.
Yleiset julkaisut
- Hu FB, Stampfer MJ, Manson JE, Grodstein F, Colditz GA, Speizer FE, Willett WC. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med. 2000 Aug 24;343(8):530-7. doi: 10.1056/NEJM200008243430802.
- Allison DB, Fontaine KR, Manson JE, Stevens J, VanItallie TB. Annual deaths attributable to obesity in the United States. JAMA. 1999 Oct 27;282(16):1530-8. doi: 10.1001/jama.282.16.1530.
- Peterson LR, Saeed IM, McGill JB, Herrero P, Schechtman KB, Gunawardena R, Recklein CL, Coggan AR, DeMoss AJ, Dence CS, Gropler RJ. Sex and type 2 diabetes: obesity-independent effects on left ventricular substrate metabolism and relaxation in humans. Obesity (Silver Spring). 2012 Apr;20(4):802-10. doi: 10.1038/oby.2011.208. Epub 2011 Aug 4.
- Folsom AR, Prineas RJ, Kaye SA, Munger RG. Incidence of hypertension and stroke in relation to body fat distribution and other risk factors in older women. Stroke. 1990 May;21(5):701-6. doi: 10.1161/01.str.21.5.701.
- Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, Speizer FE, Manson JE. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol. 1997 Apr 1;145(7):614-9. doi: 10.1093/oxfordjournals.aje.a009158.
- Lin CH, Kurup S, Herrero P, Schechtman KB, Eagon JC, Klein S, Davila-Roman VG, Stein RI, Dorn GW 2nd, Gropler RJ, Waggoner AD, Peterson LR. Myocardial oxygen consumption change predicts left ventricular relaxation improvement in obese humans after weight loss. Obesity (Silver Spring). 2011 Sep;19(9):1804-12. doi: 10.1038/oby.2011.186. Epub 2011 Jul 7.
Opintojen ennätyspäivät
Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan julkisella verkkosivustolla.
Opi tärkeimmät päivämäärät
Opiskelun aloitus
Sunnuntai 1. kesäkuuta 2003
Ensisijainen valmistuminen (Todellinen)
Sunnuntai 1. kesäkuuta 2014
Opintojen valmistuminen (Todellinen)
Sunnuntai 1. kesäkuuta 2014
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Keskiviikko 12. joulukuuta 2007
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Keskiviikko 12. joulukuuta 2007
Ensimmäinen Lähetetty (Arvio)
Torstai 13. joulukuuta 2007
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Maanantai 15. toukokuuta 2017
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Maanantai 8. toukokuuta 2017
Viimeksi vahvistettu
Maanantai 1. toukokuuta 2017
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- 05-0523 (201105066)
- P01HL013851-43 (Yhdysvaltain NIH-apuraha/sopimus)
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
EI
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .
Kliiniset tutkimukset Diet
-
USDA Grand Forks Human Nutrition Research CenterEgg Nutrition CenterLopetettu
-
University of ConnecticutUniversity of California, Berkeley; United States Army Research Institute... ja muut yhteistyökumppanitValmisKuntouttava ravitsemus lihasten palautumiseen ACL-rekonstruktiostaYhdysvallat
-
Mondelēz International, Inc.KGK Science Inc.Valmis
-
University of Alabama at BirminghamNational Multiple Sclerosis SocietyValmis
-
University of PittsburghValmisLihavuus | Sydän-ja verisuonitautiYhdysvallat
-
Mondelēz International, Inc.KGK Science Inc.Valmis
-
University of PittsburghValmisSydän-ja verisuonitaudit | LihavuusYhdysvallat
-
US Department of Veterans AffairsValmisDiabetes mellitus, tyyppi 2Yhdysvallat
-
Wolfson Medical CenterLopetettuHaavainen paksusuolitulehdusIsrael, Ranska, Italia
-
Icahn School of Medicine at Mount SinaiUniversity of Massachusetts, Worcester; The Leona M. and Harry B. Helmsley...Aktiivinen, ei rekrytointiRaskaus | Crohnin tautiYhdysvallat